Kanji Nagai
About
Kanji Nagai is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery.
According to data from OpenAlex, Kanji Nagai has authored 281 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 170 papers in Pulmonary and Respiratory Medicine, 114 papers in Oncology and 42 papers in Surgery. Recurrent topics in Kanji Nagai's work include Lung Cancer Diagnosis and Treatment (116 papers), Lung Cancer Treatments and Mutations (100 papers) and Lung Cancer Research Studies (41 papers). Kanji Nagai is often cited by papers focused on Lung Cancer Diagnosis and Treatment (116 papers), Lung Cancer Treatments and Mutations (100 papers) and Lung Cancer Research Studies (41 papers). Kanji Nagai collaborates with scholars based in Japan, United States and United Kingdom. Kanji Nagai's co-authors include Junji Yoshida, Mitsuyo Nishimura, Yutaka Nishiwaki, Atsushi Ochiai, Genichiro Ishii, Tomoyuki Hishida, Tomoyuki Yokose, Genichiro Ishii, Keiju Aokage and Kenji Suzuki and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and JNCI Journal of the National Cancer Institute.
In The Last Decade
Kanji Nagai
275 papers receiving 11.8k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Kanji Nagai Japan | 61 | 7.1k | 5.0k | 1.8k | 1.8k | 1.6k | 281 | 12.0k | ||
| Lorenzo Spaggiari Italy | 49 | 6.3k 0.9× | 2.9k 0.6× | 1.4k 0.8× | 2.0k 1.1× | 1.6k 1.0× | 507 | 10.4k | ||
| Ichiro Yoshino Japan | 56 | 6.2k 0.9× | 3.1k 0.6× | 1.3k 0.7× | 2.0k 1.1× | 2.0k 1.3× | 479 | 11.0k | ||
| Walter Weder Switzerland | 62 | 9.7k 1.4× | 3.0k 0.6× | 2.6k 1.5× | 3.9k 2.2× | 1.5k 0.9× | 434 | 15.4k | ||
| Stanley J. Goldsmith United States | 52 | 3.3k 0.5× | 2.4k 0.5× | 4.5k 2.5× | 1.5k 0.9× | 1.2k 0.8× | 223 | 9.2k | ||
| Bin S. Teh United States | 48 | 4.0k 0.6× | 2.0k 0.4× | 1.6k 0.9× | 2.0k 1.1× | 1.2k 0.8× | 374 | 8.4k | ||
| Nicolas Girard France | 47 | 4.0k 0.6× | 3.6k 0.7× | 718 0.4× | 1.0k 0.6× | 1.4k 0.9× | 417 | 8.3k | ||
| Anne‐Marie C. Dingemans Netherlands | 54 | 5.7k 0.8× | 4.9k 1.0× | 1.9k 1.0× | 796 0.4× | 1.8k 1.1× | 368 | 10.2k | ||
| Judith R. OʼFallon United States | 58 | 3.3k 0.5× | 2.2k 0.4× | 1.2k 0.7× | 950 0.5× | 2.0k 1.3× | 125 | 11.2k | ||
| Rosalba Miceli Italy | 55 | 5.4k 0.8× | 4.5k 0.9× | 397 0.2× | 2.6k 1.5× | 1.3k 0.8× | 251 | 10.6k | ||
| Vittorina Zagonel Italy | 52 | 2.4k 0.3× | 5.3k 1.1× | 695 0.4× | 1.4k 0.8× | 2.0k 1.3× | 467 | 11.4k |
Countries citing papers authored by Kanji Nagai
Since
Specialization
Citations
This map shows the geographic impact of Kanji Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanji Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanji Nagai more than expected).
Fields of papers citing papers by Kanji Nagai
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kanji Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanji Nagai. The network helps show where Kanji Nagai may publish in the future.
Co-authorship network of co-authors of Kanji Nagai
This figure shows the co-authorship network connecting the top 25 collaborators of Kanji Nagai. A scholar is included among the top collaborators of Kanji Nagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanji Nagai. Kanji Nagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Miyoshi, Tomohiro, Shigeki Umemura, Yuki Matsumura, et al.. (2016). Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Clinical Cancer Research. 23(3). 757–765.
2.
Yoshida, Junji, Genichiro Ishii, Tomoyuki Hishida, et al.. (2015). Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography--interim results. Japanese Journal of Clinical Oncology. 45(7). 677–681.
3.
Yoshida, Tatsuya, Genichiro Ishii, Kōichi Goto, et al.. (2014). Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation. Clinical Cancer Research. 21(3). 642–651.
4.
Hoshino, Ayuko, Genichiro Ishii, Tetsufumi Ito, et al.. (2011). Podoplanin-Positive Fibroblasts Enhance Lung Adenocarcinoma Tumor Formation: Podoplanin in Fibroblast Functions for Tumor Progression. Cancer Research. 71(14). 4769–4779.
5.
Yamane, Yuki, Genichiro Ishii, Kōichi Goto, et al.. (2010). A Novel Histopathological Evaluation Method Predicting the Outcome of Non-small Cell Lung Cancer Treated by Neoadjuvant Therapy: The Prognostic Importance of the Area of Residual Tumor. Journal of Thoracic Oncology. 5(1). 49–55.
6.
Otsuka, Hajime, Genichiro Ishii, Junji Yoshida, et al.. (2010). Tumor Invasion of Extralobar Soft Tissue Beyond the Hilar Region Does Not Affect the Prognosis of Surgically Resected Lung Cancer Patients. Journal of Thoracic Oncology. 5(10). 1571–1575.
7.
Kimura, Taichi, Takeshi Kuwata, Manabu Yamazaki, et al.. (2009). Targeting of Bone-Derived Insulin-Like Growth Factor-II by a Human Neutralizing Antibody Suppresses the Growth of Prostate Cancer Cells in a Human Bone Environment. Clinical Cancer Research. 16(1). 121–129.
8.
Kawase, Akikazu, Genichiro Ishii, Kanji Nagai, et al.. (2008). Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. International Journal of Cancer. 123(5). 1053–1059.
9.
Kunitoh, Hideo, H. Kato, Masahiro Tsuboi, et al.. (2008). A randomised phase II trial of preoperative chemotherapy of cisplatin–docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204). British Journal of Cancer. 99(6). 852–857.
10.
Yoshida, Junji, Genichiro Ishii, Kanji Nagai, et al.. (2007). P3-276: Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high resolution computed tomography. Journal of Thoracic Oncology. 2(8). S796–S797.
11.
Nakaya, Naoki, Kumi Saito‐Nakaya, Nobuya Akizuki, et al.. (2006). Depression and survival in patients with non‐small cell lung cancer after curative resection: a preliminary study. Cancer Science. 97(3). 199–205.
12.
Ishii, Genichiro, Atsushi Ochiai, Kiyotaka Yoh, et al.. (2006). Eg5 expression is closely correlated with response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapy. Cancer Research. 66. 1065–1065.
13.
Asamura, Hisao, Toru Kameya, Yoshihiro Matsuno, et al.. (2005). Neuroendocrine Neoplasms of the Lung: A Prognostic Spectrum. Journal of Clinical Oncology. 24(1). 70–76.
14.
Tsuta, Koji, Genichiro Ishii, Kiyotaka Yoh, et al.. (2004). Primary Lung Carcinoma With Signet-ring Cell Carcinoma Components. The American Journal of Surgical Pathology. 28(7). 868–874.
15.
Yonou, Hiroyuki, Tomoyuki Yokose, Takeshi Yoshikawa, et al.. (2004). Engraftment of Adult Human Lung Tissue in Nonobese Diabetic/Severe Combined Immunodeficient Mice: A Novel Lung Epithelial Regeneration Model. Pathobiology. 71(2). 93–102.
16.
Shiono, Satoshi, Kanji Nagai, Mitsuyo Nishimura, et al.. (2003). Pleural Dissemination Predictors Based on Preoperative and Radiological Findings in Lung Cancer Patients. Haigan. 43(6). 687–690.
17.
Suzuki, Kenji, Tsutomu Ogura, Tomoyuki Yokose, et al.. (1998). Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia. International Journal of Cancer. 79(4). 384–389.
18.
Kawasaki, Hidenori, Junji Yoshida, Tomoyuki Yokose, et al.. (1998). Primary Unknown Cancer in Pulmonary Hilar Lymph Node with Spontaneous Transient Regression: Report of a Case. Japanese Journal of Clinical Oncology. 28(6). 405–409.
19.
Kobayashi, Yasuhiko, et al.. (1985). Radionuclide angiography in pulmonary sequestration.. PubMed. 26(9). 1035–8.
20.
Hirohashi, S, Yukío Shimosato, Toru Kameya, Kanji Nagai, & Ryuichiro Tsunematsu. (1977). Hormone dependency of a serially transplantable human breast cancer (Br-10) in nude mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(9). 3184–9.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lorenzo Spaggiari Breakdown of academic impact, for papers by Ichiro Yoshino Breakdown of academic impact, for papers by Walter Weder Breakdown of academic impact, for papers by Stanley J. Goldsmith Breakdown of academic impact, for papers by Bin S. Teh Breakdown of academic impact, for papers by Nicolas Girard Breakdown of academic impact, for papers by Anne‐Marie C. Dingemans Breakdown of academic impact, for papers by Judith R. OʼFallon Breakdown of academic impact, for papers by Rosalba Miceli Breakdown of academic impact, for papers by Vittorina Zagonel